There seems to be a new, more impressive AI model every week. Given the rapid pace, how can founders best position themselves to build on top of this technology? At TechCrunch Sessions: AI, on June 5 ...
"The Variational AI scientific team has spent years quietly building a foundation model constrained to small molecule drug discovery that uses orders of magnitude less compute and data than ...
“The Variational AI scientific team has spent years quietly building a foundation model constrained to small molecule drug discovery that uses orders of magnitude less compute and data than foundation ...
Variational AI, the company behind Enkiâ„¢, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5 ...
The USD 21.7 million three-phased contract entails designing, building, and operation and ... facility with the very latest and innovative molecular imaging diagnostic technology.
Most other companies building autonomous vehicle technology ... a limit to the brute force approach of throwing more data at a model and expecting it to get smarter. “First of all, there ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results